256 related articles for article (PubMed ID: 31836012)
1. Leptin, resistin and visfatin as useful predictors of gestational diabetes mellitus.
Bawah AT; Seini MM; Abaka-Yawason A; Alidu H; Nanga S
Lipids Health Dis; 2019 Dec; 18(1):221. PubMed ID: 31836012
[TBL] [Abstract][Full Text] [Related]
2. Relationship of maternal serum resistin and visfatin levels with gestational diabetes mellitus.
Karatas A; Tunçay Işikkent N; Ozlü T; Demirin H
Gynecol Endocrinol; 2014 May; 30(5):355-8. PubMed ID: 24512558
[TBL] [Abstract][Full Text] [Related]
3. Maternal and cord blood apelin, resistin and visfatin levels in gestational diabetes mellitus.
Oncul M; Tuten A; Erman H; Gelisgen R; Benian A; Uzun H
Minerva Med; 2013 Oct; 104(5):527-35. PubMed ID: 24101110
[TBL] [Abstract][Full Text] [Related]
4. Adipokine levels in overweight women with early-onset gestational diabetes mellitus.
Lobo TF; Torloni MR; Mattar R; Nakamura MU; Alexandre SM; Daher S
J Endocrinol Invest; 2019 Feb; 42(2):149-156. PubMed ID: 29696612
[TBL] [Abstract][Full Text] [Related]
5. Adipokine levels during the first or early second trimester of pregnancy and subsequent risk of gestational diabetes mellitus: A systematic review.
Bao W; Baecker A; Song Y; Kiely M; Liu S; Zhang C
Metabolism; 2015 Jun; 64(6):756-64. PubMed ID: 25749468
[TBL] [Abstract][Full Text] [Related]
6. Circulating adipokines and mRNA expression in adipose tissue and the placenta in women with gestational diabetes mellitus.
Tsiotra PC; Halvatsiotis P; Patsouras K; Maratou E; Salamalekis G; Raptis SA; Dimitriadis G; Boutati E
Peptides; 2018 Mar; 101():157-166. PubMed ID: 29337272
[TBL] [Abstract][Full Text] [Related]
7. Plasma adipokine concentrations in overweight/obese pregnant women: a longitudinal study.
Suto M; Maeda K; Sato M; Kaji T; Irahara M
Gynecol Endocrinol; 2019 Mar; 35(3):242-246. PubMed ID: 30324835
[TBL] [Abstract][Full Text] [Related]
8. Gestational diabetes is associated with high energy and saturated fat intakes and with low plasma visfatin and adiponectin levels independent of prepregnancy BMI.
Park S; Kim MY; Baik SH; Woo JT; Kwon YJ; Daily JW; Park YM; Yang JH; Kim SH
Eur J Clin Nutr; 2013 Feb; 67(2):196-201. PubMed ID: 23385969
[TBL] [Abstract][Full Text] [Related]
9. Increased visfatin concentrations in women with gestational diabetes mellitus.
Krzyzanowska K; Krugluger W; Mittermayer F; Rahman R; Haider D; Shnawa N; Schernthaner G
Clin Sci (Lond); 2006 May; 110(5):605-9. PubMed ID: 16489932
[TBL] [Abstract][Full Text] [Related]
10. Maternal serum leptin, adiponectin, resistin and monocyte chemoattractant protein-1 levels in different types of diabetes mellitus.
Kapustin RV; Chepanov SV; Babakov VN; Rogovskaya NY; Kopteeva EV; Alekseenkova EN; Arzhanova ON
Eur J Obstet Gynecol Reprod Biol; 2020 Nov; 254():284-291. PubMed ID: 33039836
[TBL] [Abstract][Full Text] [Related]
11. Visfatin in human pregnancy: maternal gestational diabetes vis-à-vis neonatal birthweight.
Mazaki-Tovi S; Romero R; Kusanovic JP; Vaisbuch E; Erez O; Than NG; Chaiworapongsa T; Nhan-Chang CL; Pacora P; Gotsch F; Yeo L; Kim SK; Edwin SS; Hassan SS; Mittal P
J Perinat Med; 2009; 37(3):218-31. PubMed ID: 19099366
[TBL] [Abstract][Full Text] [Related]
12. Association between circulating visfatin and gestational diabetes mellitus: a systematic review and meta-analysis.
Zhang W; Zhao D; Meng Z; Wang H; Zhao K; Feng X; Li Y; Dun A; Jin X; Hou H
Acta Diabetol; 2018 Nov; 55(11):1113-1120. PubMed ID: 29992461
[TBL] [Abstract][Full Text] [Related]
13. Maternal serum visfatin at 11-13 weeks of gestation in gestational diabetes mellitus.
Ferreira AF; Rezende JC; Vaikousi E; Akolekar R; Nicolaides KH
Clin Chem; 2011 Apr; 57(4):609-13. PubMed ID: 21325104
[TBL] [Abstract][Full Text] [Related]
14. Serum visfatin concentrations in gestational diabetes mellitus and normal pregnancy.
Rezvan N; Hosseinzadeh-Attar MJ; Masoudkabir F; Moini A; Janani L; Mazaherioun M
Arch Gynecol Obstet; 2012 May; 285(5):1257-62. PubMed ID: 22167446
[TBL] [Abstract][Full Text] [Related]
15. Serum adipokines (adiponectin and resistin) correlation in developing gestational diabetes mellitus: pilot study.
Siddiqui K; George TP; Nawaz SS; Shehata N; El-Sayed AA; Khanam L
Gynecol Endocrinol; 2018 Jun; 34(6):502-506. PubMed ID: 29207892
[TBL] [Abstract][Full Text] [Related]
16. Maternal leptin, adiponectin, resistin, visfatin and tumor necrosis factor-alpha in normal and gestational diabetes.
Noureldeen AF; Qusti SY; Al-Seeni MN; Bagais MH
Indian J Clin Biochem; 2014 Oct; 29(4):462-70. PubMed ID: 25298627
[TBL] [Abstract][Full Text] [Related]
17. Adipokine levels and their association with insulin resistance and fetal outcomes among the newborns of Indian gestational diabetic mothers.
Manoharan B; Bobby Z; Dorairajan G; Vinayagam V; Packirisamy RM
Saudi Med J; 2019 Apr; 40(4):353-359. PubMed ID: 30957128
[TBL] [Abstract][Full Text] [Related]
18. Serum leptin, resistin, visfatin and adiponectin levels in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).
Cantarini L; Obici L; Simonini G; Cimaz R; Bacarelli MR; Merlini G; Vitale A; Lucherini OM; Brizi MG; Galeazzi M; Fioravanti A
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S108-14. PubMed ID: 22935190
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of diagnostic and predictive value of serum adipokines: Leptin, resistin and visfatin in postmenopausal breast cancer.
Assiri AM; Kamel HF
Obes Res Clin Pract; 2016; 10(4):442-53. PubMed ID: 26388139
[TBL] [Abstract][Full Text] [Related]
20. Maternal circulating adipokine profile and insulin resistance in women at high risk of developing gestational diabetes mellitus.
Guelfi KJ; Ong MJ; Li S; Wallman KE; Doherty DA; Fournier PA; Newnham JP; Keelan JA
Metabolism; 2017 Oct; 75():54-60. PubMed ID: 28935125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
